Eddy Anglade is the founder of Tenpoint Therapeutics. Tenpoint Therapeutics has raised $70M in total funding. Latest round: Series A. Based in London, UK.
Eddy Anglade is the CEO of Tenpoint Therapeutics, a biotechnology company focused on developing regenerative medicine for degenerative ocular diseases. The company launched with a $70 million Series A financing round to advance its platform, which aims to replace cells lost to inherited and age-related conditions. Anglade brings extensive experience in clinical development in ophthalmic diseases to his role at Tenpoint.
Full founder directory · Investor directory · Company funding database · Fundraising library